Michigan Center, MINCT05389215Now EnrollingIRB Ready

IPF Clinical Trial in Michigan Center, MI

Access cutting-edge ipf treatment through this clinical trial at a research site in Michigan Center. Study-provided care at no cost to qualified participants.

Sponsored by Daewoong Pharmaceutical Co. LTD.

Quick Self-Assessment

See if you qualify for this Michigan Center location

Preparing your pre-screening questions...

Expert Care in Michigan Center

Access ipf specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ipf treatment provided free

Apply for This Michigan Center Location

Check if you qualify for this ipf clinical trial in Michigan Center, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Michigan Center

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Michigan Center site if eligible
  4. 4Begin participation

About This IPF Study in Michigan Center

This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.

Sponsor: Daewoong Pharmaceutical Co. LTD.

Who Can Participate

Inclusion Criteria

Male or female patients aged ≥40 years based on the date of the written informed consent form
Diagnosis of IPF as defined by American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guidelines
In a stable condition and suitable for study participation based on the results of medical history, physical examination, vital signs, 12-lead ECG, and laboratory evaluation
Patients receiving local standard-of-care for IPF, defined as either pirfenidone or nintedanib, at a stable dose for at least 3 months prior to screening, or neither pirfenidone nor nintedanib. If the patients were on pirfenidone or nintedanib previously and have been off for at least 3 months prior to screening, they will be considered as not on any treatment for IPF
Meeting all of the following criteria during the screening period:
FVC ≥40% predicted of normal
DLCO corrected for Hgb ≥25% and ≤80% predicted of normal.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Michigan Center?

Yes, this clinical trial (NCT05389215) has an active research site in Michigan Center, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

IPF Treatment Options in Michigan Center, MI

If you're searching for ipf treatment options in Michigan Center, MI, this clinical trial (NCT05389215) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Michigan Center research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ipf specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ipf clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Fibrosis Trials in Michigan Center, MI

See all pulmonary fibrosis clinical trials recruiting in Michigan Center — not just this study.

Browse Pulmonary Fibrosis Trials in Michigan Center →

Browse More Trials by Condition

Pulmonary Fibrosis TrialsAll Conditions →

Ready to Join in Michigan Center?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Michigan Center, MI